15 January 2019 - EFPIA notes the UK parliament’s decision to reject the Brexit withdrawal agreement and political declaration. 

With the prospect of the UK leaving the European Union in a disorderly manner on 30 March 2019 without a deal, there are very real, tangible and immediate threats to patient safety and public health in both the UK and across Europe.

Speaking about the decision EFPIA Director General Nathalie Moll said “Now is the time for policy makers in the UK and the EU to put politics aside and put measures in place to prevent patients being harmed by the consequences of Brexit. In particular from disruption to the supply of medicines including from transport delays at the border and where the development, manufacture, packaging, safety testing and regulation of the medicine no longer benefits from mutual recognition.”

Read EFPIA press release